Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region
NCT01560832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 188
Last updated 2014-03-05
Summary
Clostridium difficile is an important pathogen, causing disease that ranges from mild self-limited diarrhea to life-threatening pseudomembranous colitis. It is estimated that C. difficile is responsible for 10% to 25% of all cases of antibiotic-associated diarrhea and for almost all cases of pseudomembranous colitis. C. difficile disease is mediated by two large toxins, A and B. The toxins damage intestinal epithelial cells and cause the clinical illness. Primary risk factors for C. difficile clinically apparent infection include antimicrobial therapy, hospitalization, residence in a long-term care facility, older age (≥ 65 years), and increased length of hospital stay. The incidence of CDI both in the hospital and the community is important in the understanding and characterization of the disease and its prevention. This observational, epidemiological study will advance the investigators understanding of CDI risk factors in several hospitals and possibly the community in the Asia Pacific region.
Conditions
- Clostridium Difficile Infection
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile
NCT05192148 ·Status: UNKNOWN ·Phase: NA
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
Molecular Epidemiology of Clostridium Difficile Infections in Children
NCT01957761 ·Status: COMPLETED
-
Clostridium Difficile Infection (CDI) in Hematologic Patients.
NCT03964844 ·Status: UNKNOWN
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825 ·Status: RECRUITING
-
Ultrasound Diagnosis of Antibiotic Associated Diarrhea
NCT00658151 ·Status: UNKNOWN
-
Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
NCT06030245 ·Status: RECRUITING
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection
NCT02086916 ·Status: COMPLETED
-
Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)
NCT01716533 ·Status: COMPLETED ·Phase: NA
-
Immune Response to C.Difficile Infection
NCT02797288 ·Status: UNKNOWN
-
Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile
NCT03025672 ·Status: COMPLETED
-
Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
NCT02200328 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Clostridioides Difficile in Infants
NCT06788769 ·Status: RECRUITING
-
Study on Clostridium Difficile Infection in Infants
NCT06703918 ·Status: RECRUITING
-
Use of Bismuth Subsalicylate in Clostridium Difficile Colitis
NCT03592082 ·Status: WITHDRAWN ·Phase: PHASE4
-
Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
NCT02148601 ·Status: COMPLETED ·Phase: PHASE2
-
FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment
NCT02570477 ·Status: UNKNOWN ·Phase: NA
-
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
NCT05770726 ·Status: RECRUITING ·Phase: NA
-
Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections
NCT01946750 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis
NCT01942447 ·Status: UNKNOWN ·Phase: NA
-
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NCT05389904 ·Status: RECRUITING ·Phase: NA